Leading cancer immunotherapy collaborations worldwide by value 2018
This statistic depicts the top immuno-oncology collaborations among pharmaceutical companies worldwide as of 2018. As of that year, the collaboration between Bristol-Myers Squibb and Nektar Therapeutics was valued 3.6 billion U.S. dollars, and thus was one of the largest immunotherapy collaborations.